Obesity in CKD - What should nephrologists know?

Journal of the American Society of Nephrology

Volumn 24, Issue 11, 2013, Pages 1727-1736

  Stenvinkel, Peter ^a   Zoccali, Carmine ^b   Ikizler, T Alp ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CNR   (Italy)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; FRUCTOSE; RAMIPRIL; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ALBUMINURIA; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; BARIATRIC SURGERY; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; COMORBIDITY; DYSLIPIDEMIA; EPIDEMIC; FATTY LIVER; GALLBLADDER DISEASE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HEREDITY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN SENSITIVITY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KINESIOTHERAPY; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; MUSCLE MASS; NEOPLASM; NEPHROLOGIST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; OBESITY; OSTEOARTHRITIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SCREENING; SEDENTARY LIFESTYLE; SLEEP DISORDERED BREATHING; WEIGHT CONTROL;

EID: 84887057297     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040330     Document Type: Article

References (118)

1. Kramer HJ, Saranathan A, Luke A., Durazo-Arvizu RA, Guichan C, Hou S., Cooper R: Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 17: 1453-1459, 2006 (Pubitemid 43673427)
2. Obermayr RP, Temml C, Knechtelsdorfer M., Gutjahr G, Kletzmayr J, Heiss S., Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R: Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 23: 1265-1273, 2008 (Pubitemid 351767507)
3. Stenvinkel P, IkizlerT A, Mallamaci F, Zoccali C: Obesity and nephrology: Results of a knowledge and practice pattern survey [published online ahead of print June 4, 2013]. Nephrol Dial Transplant doi: 10.1093/ndt/gft193
4. WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163, 2004
5. Agarwal R, Bills JE, Light RP: Diagnosing obesity by body mass index in chronic kidney disease: An explanation forthe "obesity paradox?" Hypertension 56: 893-900, 2010
6. Zoccali C, Torino C, Tripepi G., Mallamaci F: Assessment of obesity in chronic kidney disease: What is the best measure? CurrOpin Nephrol Hypertens 21: 641-646, 2012
7. Velludo CM, Kamimura MA, Sanches F.M., Lemos MM, Canziani ME, Pupim LB, Draibe S.A., Cuppari L: Prospective evaluation of waist circumference and visceral adipose tissue in patients with chronic kidney disease. Am J Nephrol 31: 104-109, 2010
8. Silva M, Vale B, Lemos C., Torres M, Bregman R: Body adiposity index assess body fat with high accuracy in nondialyzed chronic kidney disease patients. Obesity (Silver Spring) 21: 546-552, 2012
9. Valdez R, Seidell JC, Ahn Y.I., Weiss KM: A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. Int J Obes Relat Metab Disord 17: 77-82, 1993 (Pubitemid 23088118)
10. Cordeiro AC, Qureshi AR, Stenvinkel P, Heimbürger O, Axelsson J., Bárány P, Lindholm B, Carrero JJ: Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 25: 562-568, 2010
11. Honda H, Qureshi AR, Axelsson J, Heimburger O., Suliman ME, Barany P, Stenvinkel P, Lindholm B: Obese sarcopenia in patients with end-stage renal disease patients is associated with inflammation and increased mortality. Am J Clin Nutr 86: 633-638, 2007 (Pubitemid 47435829)
12. World Health Organization Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks, Geneva, World Health Organization, 2009
13. Kelly T, Yang W, Chen C-S, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32: 1431-1437, 2008
14. Yu Z, Han S, Chu J., Xu Z, Zhu C, Guo X: Trends in overweight and obesity among children and adolescents in China from 1981 to 2010: A meta-analysis. PLoS One 7: e51949, 2012
15. Gupta R, Sharma KK, Gupta A, Agrawal A., Mohan I, Gupta VP, Khedar R.S., Guptha S: Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5. J Assoc Physicians India 60: 11-16, 2012
16. Schmitt AC, Cardoso MR, Lopes H, Pereira W.M., Pereira EC, de Rezende DA, Guarizi RG, DelluM C, de MouraOliveira J, Flauzino E., Blümel JE, Aldrighi JM: Prevalence of metabolic syndrome and associated factors in women aged 35 to 65 years who were enrolled in a family health program in Brazil. Menopause 20: 470-476, 2013
17. Lagerros YT, Rössner S: Obesity management: What brings success? Therap Adv Gastroenterol 6: 77-88, 2013
18. Drong AW, Lindgren CM, McCarthy MI: The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92: 707-715, 2012
19. Yang J, Loos RJ, Powell J.E., Medland SE, Speliotes EK, Chasman DI, Rose L.M., Thorleifsson G., Steinthorsdottir V, Mägi R, Waite L., Smith AV, Yerges-Armstrong LM, Monda KL, Hadley D, Mahajan A., Li G, Kapur K, Vitart V., Huffman JE, Wang SR, Palmer C, Esko T., Fischer K, Zhao JH, Demirkan A, Isaacs A., Feitosa MF, Luan J, Heard-Costa NL, White C, Jackson A.U., Preuss M., Ziegler A, Eriksson J, Kutalik Z., Frau F, Nolte IM, Van Vliet-Ostaptchouk JV, Hottenga JJ, Jacobs KB, Verweij N, Goel A, Medina-Gomez C, Estrada K, Bragg-Gresham JL, Sanna S, Sidore C, Tyrer J, Teumer A, Prokopenko I, Mangino M, Lindgren CM, Assimes TL, Shuldiner AR, Hui J, Beilby JP, McArdle WL, Hall P, Haritunians T, Zgaga L, Kolcic I, Polasek O, Zemunik T, Oostra BA, Junttila MJ, Grönberg H, Schreiber S, Peters A, Hicks AA, Stephens J, Foad NS, Laitinen J, Pouta A, Kaakinen M, Willemsen G, Vink JM, Wild SH, Navis G, Asselbergs FW, Homuth G, John U, Iribarren C, Harris T, Launer L, Gudnason V, O'Connell JR, Boerwinkle E, Cadby G, Palmer LJ, James AL, Musk AW, Ingelsson E, Psaty BM, Beckmann JS, Waeber G, Vollenweider P, Hayward C, Wright AF, Rudan I, Groop LC, Metspalu A, Khaw KT, van Duijn CM, Borecki IB, Province MA, Wareham NJ, Tardif JC, Huikuri HV, Cupples LA, Atwood LD, Fox CS, Boehnke M, Collins FS, Mohlke KL, Erdmann J, Schunkert H, Hengstenberg C, Stark K, Lorentzon M, Ohlsson C, Cusi D, Staessen JA, Van der Klauw MM, Pramstaller PP, Kathiresan S, Jolley JD, Ripatti S, Jarvelin MR, de Geus EJ, Boomsma DI, Penninx B, Wilson JF, Campbell H, Chanock SJ, van der Harst P, Hamsten A, Watkins H, Hofman A, Witteman JC, Zillikens MC, Uitterlinden AG, Rivadeneira F, Zillikens MC, Kiemeney LA, Vermeulen SH, Abecasis GR, Schlessinger D, Schipf S, Stumvoll M, Tönjes A, Spector TD, North KE, Lettre G, McCarthy MI, Berndt SI, Heath AC, Madden PA, Nyholt DR, Montgomery GW, Martin NG, McKnight B, Strachan DP, Hill WG, Snieder H, Ridker PM, Thorsteinsdottir U, Stefansson K, Frayling TM, Hirschhorn JN, Goddard ME, Visscher PM: FTO genotype is associated with phenotypic variability of body mass index. Nature 490: 267-272, 2012
20. Spoto B, Mattace-Raso F, Sijbrands E., Mallamaci F, Leonardis D, Aucella F., Testa A, Gesuete A, Sanguedolce M.C., D'Arrigo G, Parlongo RM, Pisano A, Torino C., Enia G, Tripepi G, Postorino M., Zoccali C: The fatmass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity. Nephrol Dial Transplant 27[Suppl 4]: iv58-iv62, 2012
21. Youngson NA, Morris MJ: What obesity research tells us about epigenetic mechanisms. Philos Trans R Soc Lond B Biol Sci 368: 20110337, 2013
22. Christakis NA, Fowler JH: The spread of obesity in a large social network over 32 years. N Engl J Med 357: 370-379, 2007 (Pubitemid 47124137)
23. Johnson RJ, Segal MS, Sautin Y, Nakagawa T., Feig DI, Kang DH, Gersch MS, Benner S, Sánchez-Lozada LG: Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 86: 899-906, 2007 (Pubitemid 47538288)
24. Perez-Pozo S.E., Schold J, Nakagawa T., Sánchez-Lozada LG, Johnson RJ, Lillo JL: Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: Role of uric acid in the hypertensive response. Int J Obes (Lond) 34: 454-461, 2010
25. Bomback AS, Derebail VK, Shoham D.A., Anderson CA, Steffen LM, Rosamond WD, Kshirsagar AV: Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 77: 609-616, 2010
26. Knight JA: Physical inactivity: Associated diseases and disorders. Ann Clin Lab Sci 42: 320-337, 2012
27. WHO: Global Recommendations on Physical Activity for Health, Geneva, World Health Organization, 2010
28. Weiler R, Stamatakis E: Physical activity in the UK: A unique crossroad? Br J Sports Med 44: 912-914, 2010
29. Taubes G: Treat obesity as physiology, not physics. Nature 492: 155, 2012
30. Johnson RJ, Sanchez-Lozada LG, Nakagawa T: The effect of fructose on renal biology and disease. J Am Soc Nephrol 21: 2036-2039, 2010
31. Johnson RJ, Stenvinkel P, Martin S.L., Jani A., Sánchez-Lozada LG, Hill JO, Lanaspa MA: Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) 21: 659-664, 2013
32. Hilton C, Neville MJ, Karpe F: MicroRNAs in adipose tissue: Their role in adipogenesis and obesity. Int J Obes (Lond) 37: 325-332, 2013
33. Mitra AK, Clarke K: Viral obesity: Fact or fiction? Obes Rev 11: 289-296, 2010
34. Festi D, Schiumerini R, Birtolo C., Marzi L, Montrone L, Scaioli E., Di Biase AR, Colecchia A: Gut microbiota and its pathophysiology in disease paradigms. Dig Dis 29: 518-524, 2011
35. Karasu SR: Of mind and matter: Psychological dimensions in obesity. Am J Psychother 66: 111-128, 2012
36. Milanski M, Degasperi G, Coope A., Morari J, Denis R, Cintra D.E., Tsukumo DM, Anhe G, Amaral ME, Takahashi H.K., Curi R., Oliveira HC, Carvalheira JB, Bordin S, Saad M.J., Velloso LA: Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: Implications for the pathogenesis of obesity. J Neurosci 29: 359-370, 2009
37. Greenberg JA: Obesity and early mortality in the United States. Obesity (Silver Spring) 21: 405-412, 2013
38. Flegal KM, Kit BK, Orpana H, Graubard BI: Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA 309: 71-82, 2013
39. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E., Pilz S, Hiraki LT, Cooper J.D., Dastani Z., Li R, Houston DK, Wood A.R., Michaëlsson K, Vandenput L., Zgaga L, Yerges-Armstrong LM, McCarthy MI, Dupuis J, Kaakinen M., Kleber ME, Jameson K, Arden N, Raitakari O., Viikari J, Lohman KK, Ferrucci L, Melhus H., Ingelsson E, Byberg L, Lind L., Lorentzon M, Salomaa V, Campbell H., Dunlop M, Mitchell BD, Herzig K.H., Pouta A., Hartikainen AL, Streeten EA, Theodoratou E, Jula A., Wareham NJ, Ohlsson C, Frayling TM, Kritchevsky SB, Spector TD, Richards JB, Lehtimäki T, Ouwehand WH, Kraft P, Cooper C, März W, Power C, Loos RJ, Wang TJ, Järvelin MR, Whittaker JC, Hingorani AD, Hyppönen E; Genetic Investigation of Anthropometric Traits-GIANT Consortium: Causal relationship between obesity and vitamin D status: Bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10: e1001383, 2013
40. Priyadarshini M, Kamal MA, Greig N.H., Realef M., Abuzenadah AM, Chaudhary AG, Damanhouri GA: Alzheimer's disease and type 2 diabetes: Exploring the association to obesity and tyrosine hydroxylase. CNS Neurol Disord Drug Targets 11: 482-489, 2012
41. Rajagopalan P, Toga AW, Jack C.R., Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative: Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. Neuroreport 24: 58-62, 2013
42. Gilbert CA, Slingerland JM: Cytokines, obesity, and cancer: New insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med 64: 45-57, 2013
43. Sakaguchi Y, Shoji T, Kawabata H., Niihata K, Suzuki A, Kaneko T., Okada N, Isaka Y, Rakugi H., Tsubakihara Y: High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: A cross-sectional study. Clin J Am Soc Nephrol 6: 995-1000, 2011
44. You T, Nicklas BJ: Chronic inflammation: Role of adipose tissue and modulation by weight loss. Curr Diabetes Rev 2: 29-37, 2006 (Pubitemid 44082948)
45. Axelsson J, Rashid Qureshi A, Suliman ME, Honda H, Pecoits-Filho R, Heimbürger O, Lindholm B., Cederholm T, Stenvinkel P: Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80: 1222-1229, 2004 (Pubitemid 41350682)
46. Blüher M: Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 19: 341-346, 2012
47. Manolopoulos KN, Karpe F, Frayn KN: Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34: 949-959, 2010
48. Chertow GM, Hsu C-Y, Johansen KL: The enlarging body of evidence: Obesity and chronic kidney disease. J Am Soc Nephrol 17: 1501-1502, 2006 (Pubitemid 43794654)
49. Ejerblad E, Fored CM, Lindblad P, Fryzek J., McLaughlin JK, Nyrén O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695-1702, 2006 (Pubitemid 43794672)
50. Hsu CY, McCulloch CE, Iribarren C, Darbinian J., Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006 (Pubitemid 46780716)
51. Fox CS, Larson MG, Leip E.P., Culleton B., Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850, 2004 (Pubitemid 38543772)
52. Pinto-Sietsma S.J., Navis G, Janssen W.M., de Zeeuw D, Gans RO, de Jong PE; PREVEND Study Group: A central body fat distribution isrelatedtorenal functionimpairment, even in lean subjects. Am J Kidney Dis 41: 733-741, 2003 (Pubitemid 36401550)
53. Chen J, Muntner P, Hamm L.L., Jones DW, Batuman V, Fonseca V, Whelton P.K., He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004
54. Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten E.W., Krediet RT, le Cessie S, Wanner C, Dekker FW; NECOSAD Study Group: Association of body mass index with decline in residual kidney function after initiation of dialysis. Am J Kidney Dis 53: 1014-1023, 2009
55. Wang Y, Chen X, Song Y., Caballero B, Cheskin LJ: Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int 73: 19-33, 2008 (Pubitemid 350273639)
56. Wickman C, Kramer H: Obesity and kidney disease: Potential mechanisms. Semin Nephrol 33: 14-22, 2013
57. Kwakernaak AJ, Zelle DM, Bakker S.J., Navis G: Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol 24: 987-994, 2013
58. Warnke RA, Kempson RL: The nephrotic syndrome in massive obesity: A study by light, immunofluorescence, and electron microscopy. Arch Pathol Lab Med 102: 431-438, 1978 (Pubitemid 9004033)
59. He W, Wang Y, Zhang M.Z., You L., Davis LS, Fan H, Yang HC, Fogo A.B., Zent R., Harris RC, Breyer MD, Hao CM: Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120: 1056-1068, 2010
60. Sharma K, Ramachandrarao S, Qiu G., Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K., McCue P, Chan L, Falkner B., Goldstein BJ: Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656, 2008 (Pubitemid 351632369)
61. Wolf G, Ziyadeh FN: Leptin and renal fibrosis. Contrib Nephrol 151: 175-183, 2006 (Pubitemid 44298231)
62. Saab G, Whaley-Connell A, McFarlane S.I., Li S., Chen SC, Sowers JR, McCullough PA, Bakris GL; Kidney Early Evaluation Program Investigators: Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease. Metabolism 59: 385-389, 2010
63. Kawai M, de Paula FJ, Rosen CJ: New insights into osteoporosis: The bone-fat connection. J Intern Med 272: 317-329, 2012
64. Friedman AN, Miskulin DC, Rosenberg I.H., Levey AS: Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 41: 480-487, 2003 (Pubitemid 36152470)
65. Grosso G, Corona D, Mistretta A., Zerbo D, Sinagra N, Giaquinta A., Caglià P, Amodeo C, Leonardi A, Gula R, Veroux P, Veroux M: The role of obesity in kidney transplantation outcome. Transplant Proc 44: 1864-1868, 2012
66. Weissenbacher A, Jara M, Ulmer H., Biebl M, Bösmüller C, Schneeberger S, Mayer G, Pratschke J, Öllinger R: Recipient and donor body massindexas important risk factors for delayed kidney graft function. Transplantation 93: 524-529, 2012
67. Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S., Streja E, Krishnan M, Kalantar-Zadeh K: Higher recipient body mass index is associated with post-transplant delayed kidney graft function. Kidney Int 80: 218-224, 2011
68. Hatamizadeh P, Molnar MZ, Streja E, Lertdumrongluk P., Krishnan M, Kovesdy CP, Kalantar-Zadeh K: Recipient-related predictors of kidney transplantation outcomes in the elderly. Clin Transplant 27: 436-443, 2013
69. Streja E, Molnar MZ, Kovesdy C.P., Bunnapradist S, Jing J, Nissenson A.R., Mucsi I., Danovitch GM, Kalantar-Zadeh K: Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol 6: 1463-1473, 2011
70. Rehn TA, Winett RA, Wisløff U, Rognmo Ø: Increasing physical activity of high intensity to reduce the prevalence of chronic diseases and improve public health. Open Cardiovasc Med J 7: 1-8, 2013
71. Bharakhada N, Yates T, Davies M.J., Wilmot EG, Edwardson C, Henson J, Webb D., Khunti K: Association of sitting time and physical activity with CKD: A cross-sectional study in family practices. Am J Kidney Dis 60: 583-590, 2012
72. Wing RR, Bolin P, Brancati F.L., Bray GA, Clark JM, Coday M, Crow R.S., Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt J.P., Ghazarian S., Gregg EW, Harrison B, Hazuda HP, Hill J.O., Horton ES, Hubbard VS, Jakicic JM, Jeffery R.W., Johnson KC, Kahn SE, Kitabchi AE, Knowler W.C., Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan D.M., Patricio J., Peters A, Pi-Sunyer X, Pownall H, Reboussin D., Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden T.A., Wagenknecht LE, West DS, Williamson DF, Yanovski SZ; Look AHEAD Research Group: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369: 145-154, 2013
73. Ricardo AC, Madero M, Yang W., Anderson C, Menezes M, Fischer M.J., Turyk M., Daviglus ML, Lash JP: Adherence to a healthy lifestyle and all-cause mortality in CKD. Clin J Am Soc Nephrol 8: 602-609, 2013
74. Kiortsis DN, Christou MA: Management of obesity-induced kidney disease: A critical review of the literature. Obes Facts 5: 821-832, 2012
75. Bensimhon DR, Kraus WE, Donahue MP: Obesity and physical activity: A review. Am Heart J 151: 598-603, 2006 (Pubitemid 43290250)
76. Krikken JA, Lely AT, Bakker S.J., Navis G: The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 71: 260-265, 2007 (Pubitemid 46160927)
77. Deji N, Kume S, Araki S., Isshiki K, Araki H, Chin-Kanasaki M, Tanaka Y., Nishiyama A, Koya D, Haneda M., Kashiwagi A, Maegawa H, Uzu T: Role of angiotensin II-mediated AMPK inactivation on obesity-related saltsensitive hypertension. Biochem Biophys Res Commun 418: 559-564, 2012
78. Mallamaci F, Ruggenenti P, Perna A., Leonardis D, Tripepi R, Tripepi G., Remuzzi G, Zoccali C; REIN Study Group: ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol 22: 1122-1128, 2011
79. Tong PC, Lee ZS, Sea M.M., Chow CC, Ko GT, Chan WB, So W.Y., Ma RC, Ozaki R, Woo J, Cockram C.S., Chan JC: The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjectswith orwithouttype 2 diabetes. Arch Intern Med 162: 2428-2435, 2002 (Pubitemid 35340458)
80. Buchwald H, Avidor Y, Braunwald E., Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: A systematic review and meta-analysis. JAMA 292: 1724-1737, 2004 (Pubitemid 39346675)
81. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lönroth H, Narbro K, Näslund I, Olbers T, Svensson PA, Carlsson LM: Bariatric surgery and longterm cardiovascular events. JAMA 307: 56-65, 2012
82. Alexander JW, Goodman HR, Hawver L.R., Cardi MA: Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis 5: 237-241, 2009
83. Hou CC, Shyu RS, Lee W.J., Ser KH, Lee YC, Chen SC: Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis 9: 202-206, 2013
84. Tafti BA, Haghdoost M, Alvarez L., Curet M, Melcher ML: Recovery of renal function in a dialysis-dependent patient following gastric bypass surgery. Obes Surg 19: 1335-1339, 2009
85. Bueter M, Dubb SS, Gill A, Joannou L., Ahmed A, Frankel AH, Tam F.W., le Roux CW: Renal cytokines improve early after bariatric surgery. Br J Surg 97: 1838-1844, 2010
86. Amor A, Jiménez A, Moizé V, Ibarzabal A, Flores L, Lacy AM, Vidal J: Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery. Surg Endosc 27: 2046-2051, 2013
87. Heneghan HM, Cetin D, Navaneethan S.D., Orzech N., Brethauer SA, Schauer PR: Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis 9: 7-14, 2013
88. Turgeon NA, Perez S, Mondestin M., Davis SS, Lin E, Tata S, Kirk A.D., Larsen CP, Pearson TC, Sweeney JF: The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol 23: 885-894, 2012
89. Brzozowska MM, Sainsbury A, Eisman J.A., Baldock PA, Center JR: Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev 14: 52-67, 2013
90. Fleischmann E, Teal N, Dudley J., May W, Bower JD, Salahudeen AK: Influence of excessweight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55: 1560-1567, 1999 (Pubitemid 29157157)
91. Johansen KL, Young B, Kaysen G.A., Chertow GM: Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80: 324-332, 2004 (Pubitemid 41080005)
92. Kalantar-Zadeh K., Kopple JD, Kilpatrick R.D., McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S: Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46: 489-500, 2005 (Pubitemid 41208185)
93. Stenvinkel P, Lindholm B: Resolved: Being fat is good for dialysis patients: TheGodzilla effect: Con. J Am Soc Nephrol 19: 1062-1064, 2008
94. Carrero JJ, Qureshi AR, Axelsson J, Avesani C.M., Suliman ME, Kato S, Bárány P, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P: Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 85: 695-701, 2007 (Pubitemid 46393499)
95. Hoogeveen EK, Halbesma N, Rothman K.J., Stijnen T., van Dijk S, Dekker FW, Boeschoten E.W., de Mutsert R; Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group: Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol 7: 280-288, 2012
96. Deger SM, Sundell MB, Ikizler T.A., Hung AM: Diabetes associated oxidative stress and inflammation alters the protective effect of obesity on survival in CKD patients. Kidney Res Clin Pract 31: A28, 2012
97. Ricks J, Molnar MZ, Kovesdy C.P., Kopple JD, Norris KC, Mehrotra R, Nissenson A.R., Arah OA, Greenland S, Kalantar-Zadeh K: Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis 58: 574-582, 2011
98. Kramer H, Dugas L, Shoham D: Obesity as an effect modifier of the risk of death in chronic kidney disease [published online ahead of print September 24, 2013]. Nephrol Dial Transplant doi:10.1093/ndt/gft242
99. Park J, Jin DC, Molnar M.Z., Dukkipati R., Kim YL, Jing J, Levin NW, Nissenson A.R., Lee JS, Kalantar-Zadeh K: Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients. Mayo Clin Proc 88: 479-486, 2013
100. de Mutsert R., Snijder MB, van der Sman-de Beer F, Seidell JC, Boeschoten EW, Krediet RT, Dekker JM, Vandenbroucke JP, Dekker FW: Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 18: 967-974, 2007 (Pubitemid 46434514)
101. Evans M, Fryzek JP, Elinder C.G., Cohen SS, McLaughlin JK, Nyrén O, Fored CM: The natural history of chronic renal failure: Results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 46: 863-870, 2005 (Pubitemid 41505460)
102. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 49: 581-591, 2007 (Pubitemid 46654502)
103. Madero M, Sarnak MJ, Wang X, Sceppa C.C., Greene T., Beck GJ, Kusek JW, Collins AJ, Levey A.S., Menon V: Body mass index and mortality in CKD. Am J Kidney Dis 50: 404-411, 2007 (Pubitemid 47285452)
104. Weiner DE, Tighiouart H, Elsayed E.F., Griffith JL, Salem DN, Levey AS, Sarnak MJ: The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis 51: 212-223, 2008
105. Beddhu S, Pappas LM, Ramkumar N, Samore MH: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14: 2366-2372, 2003 (Pubitemid 37069205)
106. Noori N, Kopple JD, Kovesdy C.P., Feroze U., Sim JJ, Murali SB, Luna A, Gomez M., Luna C, Bross R, Nissenson A.R., Kalantar-Zadeh K: Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5: 2258-2268, 2010
107. Kakiya R, Shoji T, Tsujimoto Y., Tatsumi N, Hatsuda S, Shinohara K., Kimoto E, Tahara H, Koyama H., Emoto M, Ishimura E, Miki T., Tabata T, Nishizawa Y: Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int 70: 549-556, 2006 (Pubitemid 44141582)
108. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G: Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 45: 148-154, 2004 (Pubitemid 38176625)
109. Leitzmann MF, Moore SC, Koster A, Harris T.B., Park Y, Hollenbeck A, Schatzkin A: Waist circumference as compared with bodymass index in predicting mortality from specific causes. PLoS One 6: e18582, 2011
110. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith J.L., Kurth T., Salem DN, Levey AS, Weiner DE: Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52: 29-38, 2008 (Pubitemid 351853273)
111. Postorino M, Marino C, Tripepi G., Zoccali C; CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 53: 1265-1272, 2009
112. Lee PS, Sampath K, Karumanchi S.A., Tamez H., Bhan I, Isakova T, Gutierrez O.M., Wolf M., Chang Y, Stossel TP, Thadhani R: Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 20: 1140-1148, 2009
113. Lavebratt C, Wahlqvist S, Nordfors L., Hoffstedt J, Arner P: AHSG gene variant is associated with leanness among Swedish men. Hum Genet 117: 54-60, 2005 (Pubitemid 40778782)
114. Smith ER, Hanssen E, McMahon L.P., Holt SG: Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One 8: e60904, 2013
115. Bellows CF, Zhang Y, Simmons P.J., Khalsa AS, Kolonin MG: Influence of BMI on level of circulating progenitor cells. Obesity (Silver Spring) 19: 1722-1726, 2011
116. Pitanga FJ, Lessa I: Anthropometric indexes of obesity as an instrument of screening for high coronary risk in adults in the city of Salvador - Bahia. Arq Bras Cardiol 85: 26-31, 2005 (Pubitemid 41025802)
117. Dietrich MO, Liu Z-W, Horvath TL: Mitochondrial dynamics controlled by mitofusins regulate Agrp neuronal activity and diet-induced obesity. Cell 155: 188-199, 2013
118. Friedman AN, Chambers M, Kamendulis L.M., Temmerman J: Short-term changes after a weight reduction intervention in advanced diabetic nephropathy [published online ahead of print August 8, 2013]. Clin J Am Soc Nephrol doi:10.2215/CJN.04010413 Diseases